Risk of first and second primary keratinocyte cancers in relation to treatment of rheumatoid arthritis with JAKi, TNFi, and non-TNFi bDMARDs—a Swedish nationwide study

Journal:
Annals of the Rheumatic Diseases
Published:
DOI:
10.1016/j.ard.2026.02.015
Affiliations:
2
Authors:
9
Go to article
Institutions Authors Share
Karolinska Institute (KI), Sweden
7.500000
 0.83
Karolinska University Hospital, Sweden
1.500000
 0.17
Interested in Clinical Sciences?